PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases (Q47711173)

5 February 2018

title

PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases (English)

1 reference

5 February 2018

author

Giovanni Stevanin

7

1 reference

5 February 2018

Yvon Trottier

object named as

Yvon Trottier

10

0 references

Jean-Jacques Hauw

13

object named as

Jean Jacques Hauw

1 reference

5 February 2018

Charles Duyckaerts

14

object named as

Charles Duyckaerts

1 reference

5 February 2018

author name string

Junko Takahashi

1

1 reference

5 February 2018

Hiroto Fujigasaki

2

1 reference

5 February 2018

Kiyoshi Iwabuchi

3

1 reference

5 February 2018

Amalia C Bruni

4

1 reference

5 February 2018

Toshiki Uchihara

5

1 reference

5 February 2018

Khalid H El Hachimi

6

1 reference

5 February 2018

Alexandra Dürr

8

1 reference

5 February 2018

Anne Sophie Lebre

9

1 reference

5 February 2018

Hugues de Thé

11

1 reference

5 February 2018

Junichi Tanaka

12

1 reference

5 February 2018

Alexis Brice

15

1 reference

5 February 2018

publication date

1 August 2003

1 reference

5 February 2018

published in

Neurobiology of Disease

1 reference

5 February 2018

volume

13

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

230-237

1 reference

5 February 2018

Intracellular localization of proteasomal degradation of a viral antigen

cites work

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Functional architecture in the cell nucleus

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

RING for destruction?

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Role of PML and PML-RARalpha in Mad-mediated transcriptional repression

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

CREB-binding protein sequestration by expanded polyglutamine

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

PML and COP1--two proteins with much in common.

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions.

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

The PML nuclear bodies: actors or extras?

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Ataxin-3 is transported into the nucleus and associates with the nuclear matrix

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Drosophila atrophin homolog functions as a transcriptional corepressor in multiple developmental processes

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

The transcriptional role of PML and the nuclear body

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

Glutamine repeats and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016/S0969-9961(03)50080-9

7 January 2021

10.1016/S0969-9961(03)00080-9

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018